The global market for Bovine Insulin was valued at US$ 3566 million in the year 2024 and is projected to reach a revised size of US$ 4344 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Bovine Insulin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Bovine Insulin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Bovine insulin is a protein hormone secreted by pancreatic beta cells in the bovine pancreas that regulates sugar metabolism. It belongs to the class of polypeptide substances. Its molecular structure consists of two peptide chains, A and B. Chain A contains 21 amino acids and chain B contains 30 amino acids. They are connected by disulfide bonds to form a double-chain molecule. It is one of the smallest proteins with a clear chemical structure. The hormone plays a role in lowering blood sugar by promoting the entry of glucose into cells and inhibiting glycogenolysis and gluconeogenesis, while participating in the regulation of fat and protein metabolism. Bovine insulin is similar in structure to human insulin, but there are two amino acid differences (alanine and valine at the 8th and 10th positions of the A chain, respectively), which may trigger an immune response. In the early days, due to biotechnology restrictions, bovine insulin was used as the main drug for the treatment of diabetes. Later, with the development of recombinant DNA technology, human insulin and insulin analogs gradually replaced its mainstream position due to lower immunogenicity and higher safety. Nowadays, bovine insulin is mostly used in scientific research.

North American market for Bovine Insulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Bovine Insulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Bovine Insulin include Merck, Thermo Fisher Scientific, Novo Nordisk, Bio-Techne, MP Biomedicals, TargetMol, GenScript, APExBIO, Cell Applications, GeminiBio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bovine Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Insulin.

The Bovine Insulin market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bovine Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bovine Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bovine Insulin Market Report

Report Metric	Details
Report Name	Bovine Insulin Market
Accounted market size in year	US$ 3566 million
Forecasted market size in 2031	US$ 4344 million
CAGR	2.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Natural Synthetic
Segment by Application	Biomedical Research Pharmaceutical Industry Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Thermo Fisher Scientific, Novo Nordisk, Bio-Techne, MP Biomedicals, TargetMol, GenScript, APExBIO, Cell Applications, GeminiBio, Tonghua Dongbao Pharmaceuticals, Jiangsu Wanbang Biochemical Pharmaceutical Group, Shenzhen Hanyu Pharmaceuticals, Shanghai Maokang Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Bovine Insulin Market growing?

Ans: The Bovine Insulin Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Bovine Insulin Market size in 2031?

Ans: The Bovine Insulin Market size in 2031 will be US$ 4344 million.

Who are the main players in the Bovine Insulin Market report?

Ans: The main players in the Bovine Insulin Market are Merck, Thermo Fisher Scientific, Novo Nordisk, Bio-Techne, MP Biomedicals, TargetMol, GenScript, APExBIO, Cell Applications, GeminiBio, Tonghua Dongbao Pharmaceuticals, Jiangsu Wanbang Biochemical Pharmaceutical Group, Shenzhen Hanyu Pharmaceuticals, Shanghai Maokang Biotechnology

What are the Application segmentation covered in the Bovine Insulin Market report?

Ans: The Applications covered in the Bovine Insulin Market report are Biomedical Research, Pharmaceutical Industry, Other

What are the Type segmentation covered in the Bovine Insulin Market report?

Ans: The Types covered in the Bovine Insulin Market report are Natural, Synthetic

1 Bovine Insulin Market Overview

1.1 Product Definition

1.2 Bovine Insulin by Type

1.2.1 Global Bovine Insulin Market Value Comparison by Type (2024 VS 2031)

1.2.2 Natural

1.2.3 Synthetic

1.3 Bovine Insulin by Application

1.3.1 Global Bovine Insulin Market Value by Application (2024 VS 2031)

1.3.2 Biomedical Research

1.3.3 Pharmaceutical Industry

1.3.4 Other

1.4 Global Bovine Insulin Market Size Estimates and Forecasts

1.4.1 Global Bovine Insulin Revenue 2020-2031

1.4.2 Global Bovine Insulin Sales 2020-2031

1.4.3 Global Bovine Insulin Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Bovine Insulin Market Competition by Manufacturers

2.1 Global Bovine Insulin Sales Market Share by Manufacturers (2020-2025)

2.2 Global Bovine Insulin Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Bovine Insulin Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Bovine Insulin, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bovine Insulin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bovine Insulin, Product Type & Application

2.7 Global Key Manufacturers of Bovine Insulin, Date of Enter into This Industry

2.8 Global Bovine Insulin Market Competitive Situation and Trends

2.8.1 Global Bovine Insulin Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bovine Insulin Players Market Share by Revenue

2.8.3 Global Bovine Insulin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bovine Insulin Market Scenario by Region

3.1 Global Bovine Insulin Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Bovine Insulin Sales by Region: 2020-2031

3.2.1 Global Bovine Insulin Sales by Region: 2020-2025

3.2.2 Global Bovine Insulin Sales by Region: 2026-2031

3.3 Global Bovine Insulin Revenue by Region: 2020-2031

3.3.1 Global Bovine Insulin Revenue by Region: 2020-2025

3.3.2 Global Bovine Insulin Revenue by Region: 2026-2031

3.4 North America Bovine Insulin Market Facts & Figures by Country

3.4.1 North America Bovine Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Bovine Insulin Sales by Country (2020-2031)

3.4.3 North America Bovine Insulin Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bovine Insulin Market Facts & Figures by Country

3.5.1 Europe Bovine Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Bovine Insulin Sales by Country (2020-2031)

3.5.3 Europe Bovine Insulin Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bovine Insulin Market Facts & Figures by Region

3.6.1 Asia Pacific Bovine Insulin Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Bovine Insulin Sales by Region (2020-2031)

3.6.3 Asia Pacific Bovine Insulin Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Bovine Insulin Market Facts & Figures by Country

3.7.1 Latin America Bovine Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Bovine Insulin Sales by Country (2020-2031)

3.7.3 Latin America Bovine Insulin Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Bovine Insulin Market Facts & Figures by Country

3.8.1 Middle East and Africa Bovine Insulin Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Bovine Insulin Sales by Country (2020-2031)

3.8.3 Middle East and Africa Bovine Insulin Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bovine Insulin Sales by Type (2020-2031)

4.1.1 Global Bovine Insulin Sales by Type (2020-2025)

4.1.2 Global Bovine Insulin Sales by Type (2026-2031)

4.1.3 Global Bovine Insulin Sales Market Share by Type (2020-2031)

4.2 Global Bovine Insulin Revenue by Type (2020-2031)

4.2.1 Global Bovine Insulin Revenue by Type (2020-2025)

4.2.2 Global Bovine Insulin Revenue by Type (2026-2031)

4.2.3 Global Bovine Insulin Revenue Market Share by Type (2020-2031)

4.3 Global Bovine Insulin Price by Type (2020-2031)

5 Segment by Application

5.1 Global Bovine Insulin Sales by Application (2020-2031)

5.1.1 Global Bovine Insulin Sales by Application (2020-2025)

5.1.2 Global Bovine Insulin Sales by Application (2026-2031)

5.1.3 Global Bovine Insulin Sales Market Share by Application (2020-2031)

5.2 Global Bovine Insulin Revenue by Application (2020-2031)

5.2.1 Global Bovine Insulin Revenue by Application (2020-2025)

5.2.2 Global Bovine Insulin Revenue by Application (2026-2031)

5.2.3 Global Bovine Insulin Revenue Market Share by Application (2020-2031)

5.3 Global Bovine Insulin Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Bovine Insulin Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Thermo Fisher Scientific

6.2.1 Thermo Fisher Scientific Company Information

6.2.2 Thermo Fisher Scientific Description and Business Overview

6.2.3 Thermo Fisher Scientific Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Thermo Fisher Scientific Bovine Insulin Product Portfolio

6.2.5 Thermo Fisher Scientific Recent Developments/Updates

6.3 Novo Nordisk

6.3.1 Novo Nordisk Company Information

6.3.2 Novo Nordisk Description and Business Overview

6.3.3 Novo Nordisk Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novo Nordisk Bovine Insulin Product Portfolio

6.3.5 Novo Nordisk Recent Developments/Updates

6.4 Bio-Techne

6.4.1 Bio-Techne Company Information

6.4.2 Bio-Techne Description and Business Overview

6.4.3 Bio-Techne Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bio-Techne Bovine Insulin Product Portfolio

6.4.5 Bio-Techne Recent Developments/Updates

6.5 MP Biomedicals

6.5.1 MP Biomedicals Company Information

6.5.2 MP Biomedicals Description and Business Overview

6.5.3 MP Biomedicals Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.5.4 MP Biomedicals Bovine Insulin Product Portfolio

6.5.5 MP Biomedicals Recent Developments/Updates

6.6 TargetMol

6.6.1 TargetMol Company Information

6.6.2 TargetMol Description and Business Overview

6.6.3 TargetMol Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.6.4 TargetMol Bovine Insulin Product Portfolio

6.6.5 TargetMol Recent Developments/Updates

6.7 GenScript

6.7.1 GenScript Company Information

6.7.2 GenScript Description and Business Overview

6.7.3 GenScript Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.7.4 GenScript Bovine Insulin Product Portfolio

6.7.5 GenScript Recent Developments/Updates

6.8 APExBIO

6.8.1 APExBIO Company Information

6.8.2 APExBIO Description and Business Overview

6.8.3 APExBIO Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.8.4 APExBIO Bovine Insulin Product Portfolio

6.8.5 APExBIO Recent Developments/Updates

6.9 Cell Applications

6.9.1 Cell Applications Company Information

6.9.2 Cell Applications Description and Business Overview

6.9.3 Cell Applications Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cell Applications Bovine Insulin Product Portfolio

6.9.5 Cell Applications Recent Developments/Updates

6.10 GeminiBio

6.10.1 GeminiBio Company Information

6.10.2 GeminiBio Description and Business Overview

6.10.3 GeminiBio Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.10.4 GeminiBio Bovine Insulin Product Portfolio

6.10.5 GeminiBio Recent Developments/Updates

6.11 Tonghua Dongbao Pharmaceuticals

6.11.1 Tonghua Dongbao Pharmaceuticals Company Information

6.11.2 Tonghua Dongbao Pharmaceuticals Description and Business Overview

6.11.3 Tonghua Dongbao Pharmaceuticals Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Tonghua Dongbao Pharmaceuticals Bovine Insulin Product Portfolio

6.11.5 Tonghua Dongbao Pharmaceuticals Recent Developments/Updates

6.12 Jiangsu Wanbang Biochemical Pharmaceutical Group

6.12.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Company Information

6.12.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Description and Business Overview

6.12.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Product Portfolio

6.12.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates

6.13 Shenzhen Hanyu Pharmaceuticals

6.13.1 Shenzhen Hanyu Pharmaceuticals Company Information

6.13.2 Shenzhen Hanyu Pharmaceuticals Description and Business Overview

6.13.3 Shenzhen Hanyu Pharmaceuticals Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shenzhen Hanyu Pharmaceuticals Bovine Insulin Product Portfolio

6.13.5 Shenzhen Hanyu Pharmaceuticals Recent Developments/Updates

6.14 Shanghai Maokang Biotechnology

6.14.1 Shanghai Maokang Biotechnology Company Information

6.14.2 Shanghai Maokang Biotechnology Description and Business Overview

6.14.3 Shanghai Maokang Biotechnology Bovine Insulin Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Shanghai Maokang Biotechnology Bovine Insulin Product Portfolio

6.14.5 Shanghai Maokang Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bovine Insulin Industry Chain Analysis

7.2 Bovine Insulin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bovine Insulin Production Mode & Process Analysis

7.4 Bovine Insulin Sales and Marketing

7.4.1 Bovine Insulin Sales Channels

7.4.2 Bovine Insulin Distributors

7.5 Bovine Insulin Customer Analysis

8 Bovine Insulin Market Dynamics

8.1 Bovine Insulin Industry Trends

8.2 Bovine Insulin Market Drivers

8.3 Bovine Insulin Market Challenges

8.4 Bovine Insulin Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Merck

Thermo Fisher Scientific

Jiangsu Wanbang Biochemical Pharmaceutical Group

Shanghai Maokang Biotechnology

Tonghua Dongbao Pharmaceuticals

Shenzhen Hanyu Pharmaceuticals

List of Tables

Table 1. Global Bovine Insulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Bovine Insulin Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Bovine Insulin Market Competitive Situation by Manufacturers in 2024

Table 4. Global Bovine Insulin Sales (g) of Key Manufacturers (2020-2025)

Table 5. Global Bovine Insulin Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Bovine Insulin Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Bovine Insulin Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Bovine Insulin Average Price (US$/mg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Bovine Insulin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bovine Insulin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bovine Insulin, Product Type & Application

Table 12. Global Key Manufacturers of Bovine Insulin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bovine Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Insulin as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bovine Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Bovine Insulin Sales by Region (2020-2025) & (g)

Table 18. Global Bovine Insulin Sales Market Share by Region (2020-2025)

Table 19. Global Bovine Insulin Sales by Region (2026-2031) & (g)

Table 20. Global Bovine Insulin Sales Market Share by Region (2026-2031)

Table 21. Global Bovine Insulin Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Bovine Insulin Revenue Market Share by Region (2020-2025)

Table 23. Global Bovine Insulin Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Bovine Insulin Revenue Market Share by Region (2026-2031)

Table 25. North America Bovine Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Bovine Insulin Sales by Country (2020-2025) & (g)

Table 27. North America Bovine Insulin Sales by Country (2026-2031) & (g)

Table 28. North America Bovine Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Bovine Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Bovine Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Bovine Insulin Sales by Country (2020-2025) & (g)

Table 32. Europe Bovine Insulin Sales by Country (2026-2031) & (g)

Table 33. Europe Bovine Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Bovine Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Bovine Insulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Bovine Insulin Sales by Region (2020-2025) & (g)

Table 37. Asia Pacific Bovine Insulin Sales by Region (2026-2031) & (g)

Table 38. Asia Pacific Bovine Insulin Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Bovine Insulin Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bovine Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Bovine Insulin Sales by Country (2020-2025) & (g)

Table 42. Latin America Bovine Insulin Sales by Country (2026-2031) & (g)

Table 43. Latin America Bovine Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bovine Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Bovine Insulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Bovine Insulin Sales by Country (2020-2025) & (g)

Table 47. Middle East and Africa Bovine Insulin Sales by Country (2026-2031) & (g)

Table 48. Middle East and Africa Bovine Insulin Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Bovine Insulin Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Bovine Insulin Sales (g) by Type (2020-2025)

Table 51. Global Bovine Insulin Sales (g) by Type (2026-2031)

Table 52. Global Bovine Insulin Sales Market Share by Type (2020-2025)

Table 53. Global Bovine Insulin Sales Market Share by Type (2026-2031)

Table 54. Global Bovine Insulin Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Bovine Insulin Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Bovine Insulin Revenue Market Share by Type (2020-2025)

Table 57. Global Bovine Insulin Revenue Market Share by Type (2026-2031)

Table 58. Global Bovine Insulin Price (US$/mg) by Type (2020-2025)

Table 59. Global Bovine Insulin Price (US$/mg) by Type (2026-2031)

Table 60. Global Bovine Insulin Sales (g) by Application (2020-2025)

Table 61. Global Bovine Insulin Sales (g) by Application (2026-2031)

Table 62. Global Bovine Insulin Sales Market Share by Application (2020-2025)

Table 63. Global Bovine Insulin Sales Market Share by Application (2026-2031)

Table 64. Global Bovine Insulin Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Bovine Insulin Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Bovine Insulin Revenue Market Share by Application (2020-2025)

Table 67. Global Bovine Insulin Revenue Market Share by Application (2026-2031)

Table 68. Global Bovine Insulin Price (US$/mg) by Application (2020-2025)

Table 69. Global Bovine Insulin Price (US$/mg) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 73. Merck Bovine Insulin Product

Table 74. Merck Recent Developments/Updates

Table 75. Thermo Fisher Scientific Company Information

Table 76. Thermo Fisher Scientific Description and Business Overview

Table 77. Thermo Fisher Scientific Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 78. Thermo Fisher Scientific Bovine Insulin Product

Table 79. Thermo Fisher Scientific Recent Developments/Updates

Table 80. Novo Nordisk Company Information

Table 81. Novo Nordisk Description and Business Overview

Table 82. Novo Nordisk Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 83. Novo Nordisk Bovine Insulin Product

Table 84. Novo Nordisk Recent Developments/Updates

Table 85. Bio-Techne Company Information

Table 86. Bio-Techne Description and Business Overview

Table 87. Bio-Techne Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 88. Bio-Techne Bovine Insulin Product

Table 89. Bio-Techne Recent Developments/Updates

Table 90. MP Biomedicals Company Information

Table 91. MP Biomedicals Description and Business Overview

Table 92. MP Biomedicals Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 93. MP Biomedicals Bovine Insulin Product

Table 94. MP Biomedicals Recent Developments/Updates

Table 95. TargetMol Company Information

Table 96. TargetMol Description and Business Overview

Table 97. TargetMol Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 98. TargetMol Bovine Insulin Product

Table 99. TargetMol Recent Developments/Updates

Table 100. GenScript Company Information

Table 101. GenScript Description and Business Overview

Table 102. GenScript Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 103. GenScript Bovine Insulin Product

Table 104. GenScript Recent Developments/Updates

Table 105. APExBIO Company Information

Table 106. APExBIO Description and Business Overview

Table 107. APExBIO Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 108. APExBIO Bovine Insulin Product

Table 109. APExBIO Recent Developments/Updates

Table 110. Cell Applications Company Information

Table 111. Cell Applications Description and Business Overview

Table 112. Cell Applications Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 113. Cell Applications Bovine Insulin Product

Table 114. Cell Applications Recent Developments/Updates

Table 115. GeminiBio Company Information

Table 116. GeminiBio Description and Business Overview

Table 117. GeminiBio Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 118. GeminiBio Bovine Insulin Product

Table 119. GeminiBio Recent Developments/Updates

Table 120. Tonghua Dongbao Pharmaceuticals Company Information

Table 121. Tonghua Dongbao Pharmaceuticals Description and Business Overview

Table 122. Tonghua Dongbao Pharmaceuticals Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 123. Tonghua Dongbao Pharmaceuticals Bovine Insulin Product

Table 124. Tonghua Dongbao Pharmaceuticals Recent Developments/Updates

Table 125. Jiangsu Wanbang Biochemical Pharmaceutical Group Company Information

Table 126. Jiangsu Wanbang Biochemical Pharmaceutical Group Description and Business Overview

Table 127. Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 128. Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Product

Table 129. Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates

Table 130. Shenzhen Hanyu Pharmaceuticals Company Information

Table 131. Shenzhen Hanyu Pharmaceuticals Description and Business Overview

Table 132. Shenzhen Hanyu Pharmaceuticals Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 133. Shenzhen Hanyu Pharmaceuticals Bovine Insulin Product

Table 134. Shenzhen Hanyu Pharmaceuticals Recent Developments/Updates

Table 135. Shanghai Maokang Biotechnology Company Information

Table 136. Shanghai Maokang Biotechnology Description and Business Overview

Table 137. Shanghai Maokang Biotechnology Bovine Insulin Sales (g), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2020-2025)

Table 138. Shanghai Maokang Biotechnology Bovine Insulin Product

Table 139. Shanghai Maokang Biotechnology Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Bovine Insulin Distributors List

Table 143. Bovine Insulin Customers List

Table 144. Bovine Insulin Market Trends

Table 145. Bovine Insulin Market Drivers

Table 146. Bovine Insulin Market Challenges

Table 147. Bovine Insulin Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bovine Insulin

Figure 2. Global Bovine Insulin Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bovine Insulin Market Share by Type: 2024 & 2031

Figure 4. Natural Product Picture

Figure 5. Synthetic Product Picture

Figure 6. Global Bovine Insulin Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Bovine Insulin Market Share by Application: 2024 & 2031

Figure 8. Biomedical Research

Figure 9. Pharmaceutical Industry

Figure 10. Other

Figure 11. Global Bovine Insulin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Bovine Insulin Market Size (2020-2031) & (US$ Million)

Figure 13. Global Bovine Insulin Sales (2020-2031) & (g)

Figure 14. Global Bovine Insulin Average Price (US$/mg) & (2020-2031)

Figure 15. Bovine Insulin Report Years Considered

Figure 16. Bovine Insulin Sales Share by Manufacturers in 2024

Figure 17. Global Bovine Insulin Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Bovine Insulin Players: Market Share by Revenue in Bovine Insulin in 2024

Figure 19. Bovine Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Bovine Insulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Bovine Insulin Sales Market Share by Country (2020-2031)

Figure 22. North America Bovine Insulin Revenue Market Share by Country (2020-2031)

Figure 23. United States Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Bovine Insulin Sales Market Share by Country (2020-2031)

Figure 26. Europe Bovine Insulin Revenue Market Share by Country (2020-2031)

Figure 27. Germany Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Bovine Insulin Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Bovine Insulin Revenue Market Share by Region (2020-2031)

Figure 34. China Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Bovine Insulin Sales Market Share by Country (2020-2031)

Figure 42. Latin America Bovine Insulin Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Bovine Insulin Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Bovine Insulin Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Bovine Insulin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Bovine Insulin by Type (2020-2031)

Figure 53. Global Revenue Market Share of Bovine Insulin by Type (2020-2031)

Figure 54. Global Bovine Insulin Price (US$/mg) by Type (2020-2031)

Figure 55. Global Sales Market Share of Bovine Insulin by Application (2020-2031)

Figure 56. Global Revenue Market Share of Bovine Insulin by Application (2020-2031)

Figure 57. Global Bovine Insulin Price (US$/mg) by Application (2020-2031)

Figure 58. Bovine Insulin Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions